InterSystems Pushes AI-Native RME to EU Standards, Hospitals Get a Safer Bet

Author: Qoo Media

InterSystems has moved its AI-native electronic medical record system, InterSystems IntelliCare, into a new regulatory category by securing Medical Device Class IIa certification under the European Union’s Medical Device Regulation (MDR) 2017/745. The approval places the platform among the first AI-native RME systems in the world to meet the EU’s strict safety and quality requirements.

For healthcare providers, the certification matters beyond compliance. It signals that artificial intelligence can be embedded into clinical systems with a stronger focus on safety, accountability, and operational reliability.

AI built into the core, not added on top

InterSystems says IntelliCare is different from many systems on the market because its AI is not presented as an extra feature. Instead, the technology is built natively on the InterSystems TrakCare platform, so the entire system is designed to work as one integrated product.

That approach is meant to make AI easier to manage inside hospitals and clinics. It also supports a broader goal of reducing administrative burden, one of the pressures often linked to clinician fatigue.

Designed to ease clinical workloads

IntelliCare is built to deliver instant patient summaries, support clinical documentation, and provide AI-based conversational tools. The platform is positioned to help healthcare workers move faster without sacrificing accuracy in medical records.

One of its central functions is to automatically capture and organize clinical information during care delivery. That can shorten workflows and give medical staff more time to focus on patients.

Human review remains mandatory

Even with AI inside the system, InterSystems says control remains with healthcare professionals. Any documentation suggestion or medical action produced by the platform must be reviewed and approved by clinicians before it is used.

This principle is increasingly important as healthcare organizations pay closer attention to AI governance. InterSystems is framing the platform as a tool to assist clinical judgment, not replace it.

Don Woodlock, President of InterSystems, said the company is setting a new standard for the role of AI in healthcare. He said AI should be a core part of healthcare applications, not just an experimental add-on.

Why the certification matters in Indonesia

For healthcare providers in Indonesia, internationally recognized certifications such as MDR can strengthen confidence in data security and system quality. That is especially relevant for facilities that need trusted electronic records systems to manage patient information safely.

InterSystems says its operations already reach more than 80 countries. Its emphasis on interoperability and scalability reflects the direction of digital health platforms that depend increasingly on standardized and resilient data infrastructure.

The certification also reinforces a larger trend in healthcare technology: AI is moving from a promising feature to a regulated component of core clinical systems. For hospitals and clinics, that shift may shape how future electronic record platforms are selected, deployed, and trusted.

Source: www.medcom.id
Latest